• Profile
Close
Sign Up / Log In
Journal Summaries
Gastroenterology
  Pharmacology/Therapy

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Pharmacology/Therapy

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Pharmacology/Therapy

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Pharmacology/Therapy

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HPB | Feb 11, 2022 Pharmacology/Therapy

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Pharmacology/Therapy

Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

New England Journal of Medicine | Feb 08, 2022 Pharmacology/Therapy

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Journal of Gastroenterology and Hepatology | Jan 28, 2022 Pharmacology/Therapy

Most read this week
1

Pelvic Floor Disorders: Causes, Diagnosis & Treatment
Placeholder
2

'Weekend Warrior' Trend: Health Perks for Busy Physicians
Placeholder
3

Minimally Invasive Dentistry
Placeholder
4

Leptin Hormone: Its Role in Food Intake & Energy Expenditure
Placeholder
5

More Women Experience Chronic Pain Than Men: Find Out Why
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay